Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details Textual)

v3.19.2
Summary of Significant Accounting Policies (Details Textual) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Apr. 25, 2019
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Summary of Significant Accounting Policies (Textual)            
Non-controlling interest rate 21.833%          
Inventory reserve   $ 12,500   $ 12,500   $ 12,500
Customer discounts, returns and rebates   161,000 $ 131,000 713,000 $ 220,000  
Reserve for sales returns and allowances       83,000   43,000
Accounts receivable reserve   0   $ 0   0
Income tax, description       More than 50%    
Noncontrolling interests, description       The Company accounts for its less than 100% interests in CVLB RX and LegalSimpli in accordance with ASC Topic 810, Consolidation, and accordingly the Company presents noncontrolling interests as a component of equity on its consolidated balance sheet and reports the noncontrolling interest’s share of the Conversion Labs PR, and LegalSimpli’s net loss attributable to noncontrolling interests in the consolidated statement of operations.    
Product deposit   131,000   $ 131,000   33,000
Percentage of variable interest entities       51.00%    
Inventory balances   703,286   $ 703,286   $ 1,022,616
Operating loss carryforwards for federal   $ 5,370,000   $ 5,370,000    
Description of concentration of credit risk       The Company’s accounts receivable had no significant concentration from any one customer. As of June 30, 2019, three credit card processors accounted for 65%, 21% and 11% of accounts receivable.    
Credit risk percentage       90.00%    
Percentage of ownership equity interest   100.00%   100.00%    
Employee Stock Option [Member] | Warrant [Member]            
Summary of Significant Accounting Policies (Textual)            
Antidilutive securities excluded from computation of earnings per share   13,600 8,210,800 13,600 6,090,111